Navigation Links
Kettering in Medical News

DermTech Adds Allan C. Halpern, MD, Chief of Dermatology at Memorial Sloan- Kettering Cancer Center, to Company's Melanoma Advisory Board

LA JOLLA, Calif., March 5 /PRNewswire/ -- DermTech, a biotechnology company developing molecular diagnostics for the early detection of melanoma and other diseases, today announced that Allan C. Halpern, MD, has joined DermTech's Melanoma Advisory Board. Dr. Halpern is Chief of Dermatology at ...

Ongoing Study Shows That Endovascular Therapy is Associated With High Cure Rate for Childhood Eye Cancer

...ma," says Gobin, who says that the study is the product of teamwork between New York Presbyterian Hospital and the Eye Cancer Center of Memorial Sloan kettering Cancer Center, New York City, with support from David Abramson, M.D., Brian Marr, M.D., Ira Dunkel, M.D. And Scott Brodie, M.D. Retinoblastoma,...

New drug candidate prolongs the lives of pancreatic cancer patients

...action of Ras in the tumor itself. For this study, Salirasib was licensed by Concordia Pharmaceuticals, which collaborated with the Memorial Sloan kettering Cancer Center, Johns Hopkins, the M.D. Anderson Cancer Center and other institutes in the United States. If Phase II/III trials are successful, Pro...

Promising medical trainees receive funding to pursue research in hematology

...dicine Andrew Marshall, Fox Chase Cancer Center Laura Myers, BA, Harvard Medical School, Brigham and Women's Hospital Jay Patel, BA, Memorial Sloan kettering Cancer Center Siayareh Rambally, BS, Baylor College of Medicine Katherine Ryken, University of Iowa College of Medicine Umar Salimi, BA, University...

Public Ready for Changes to Health-Care System But Unclear About Necessary Trade-Offs, Citizen Forums Suggest

...ustained, according to new research released today by Public Agenda and the kettering Foundation. The report, Public Thinking about Coping with the Cost of...zations, whose common interest is to promote public deliberation. kettering Foundation ( www.kettering.org ) is a research organization, focused on ...

Health Care Finance to Implement District's First Medicaid 'Patient Data Hub' Using MedPlus Technology

... among the largest HIE's in the nation, with 8 of its 12 member hospitals operating in Manhattan, including Beth Israel Medical Center, Memorial Sloan kettering Hospital, Mount Sinai Medical Center, and New York Presbyterian Hospital. "The District of Columbia is leading the nation by example in its laun...

Photos: The Nation's Leading Scientists and Top Rock Stars Shine a Spotlight on the Promise of Medical Research

...r discovery of cancer genes, former director of the National Institutes of Health, and advisor to President Obama and Gates Foundation (Memorial Sloan kettering Cancer Center) Anthony S. Fauci , MD, global expert on HIV/AIDS and key advisor to the White House and Department of Health and Human Servic...

Aragon Pharmaceuticals Announces $8 Million Series A Financing

...aceuticals is a San Diego-based biopharmaceutical company built on the pioneering research of Charles Sawyers, M.D., an investigator at Memorial Sloan kettering Cancer Center and the Howard Hughes Medical Institute, and Michael Jung, Ph.D., a professor at UCLA , who are founders of Aragon. Their recent disco...

Research Findings on Nine GlaxoSmithKline Cancer Compounds to be Presented at ASCO 2009

...089), a dual MET/VEGFR2 inhibitor, in metastatic gastric cancer (GC): Interim results of a multicenter phase II study." Dr. M. A. Shah, Memorial-Sloan kettering Cancer Center; Presentation on May 30. Breast Cancer: Investigational data on new biomarkers in TYKERB(R)/TYVERB(R) (lapatinib) ba...

ASGE recognizes 68 endoscopy units for quality and safety through endoscopy unit recognition program

...eat Neck Endoscopy, Great Neck, NJ Gulf Coast Endoscopy Center, Fort Meyers, FL Highland Endoscopy Center, Malvern, PA Huron Gastro, Ypsilanti, MI kettering Hospital GI Unit, Kettering, OH Kinston Medical Specialists P.A., Kinston, NC Lake Forest Endoscopy Center, LLC, Lake Forest, IL Lincoln Endoscopy ...
Kettering in Medical Technology

Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center

... by external grants. Ron Bentsur, Chief Executive Officer of Keryx Biopharmaceuticals, commented, "We're very excited that Memorial-Sloan kettering has taken on a leadership role in the first pediatric study of perifosine." Mr. Bentsur continued, "We are extremely grateful for the external finan...

Neurobiological Technologies' Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program

... brain tumor models, in addition to assessment of angiogenesis inhibition potential. These placebo-controlled studies were conducted at Memorial Sloan kettering Cancer Center in New York as well as Duke University and the Piedmont Research Center, both in North Carolina. The tumor assessment studies were co...

Study Shows How Defective DNA Repair Triggers Two Neurological Diseases

...r authors of this paper include Erin Shull, Youngsoo Lee, Jingfeng Zhao and Helen Russell (St. Jude); John Petrini and Travis Stracker (Memorial Sloan kettering Cancer Center and Cornell University Graduate School of Medical Sciences); and Hironobu Nakane (formerly of St. Jude). This research was suppor...

IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program

...arcoma patients through a compassionate access study. The compassionate access study is being conducted initially at M. D. Anderson and Memorial-Sloan kettering Cancer Center in New York. "Patients are our first priority and we are committed to providing L-MTP- PE to those who desperately need treatment," sa...

IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study

...date with good quality of life." Study background The compassionate access study is being conducted initially at M. D. Anderson and Memorial-Sloan kettering Cancer Center in New York. Eligible patients will have a confirmed diagnosis of high grade osteosarcoma with relapsed or recurrent disease, locally or...

FluoroPharma Announces Positive Phase I Safety Results for CardioPET(TM), Coronary Artery Disease (CAD) Imaging Tracer for Positron Emission Tomography (PET)

... shows early promise and may hold the key to better quality CAD diagnoses." Dr. Strauss is the Clinical Director of Nuclear Medicine at Memorial Sloan kettering Cancer Center and Professor of Radiology at Cornell University's Weill School of Medicine. "The FluoroPharma team is pleased and encouraged by the P...

IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients

...cularly when compared to the outcome of these patients for the last 20 years," said Dr. Meyers, vice chair, department of pediatrics at Memorial Sloan kettering Cancer Center and principal investigator of the Phase 3 trial. "These results are especially encouraging for the critically ill children and young adu...

IDM Pharma Announces Upcoming Clinical Data Presentations

...xorubicin, High Dose Methotrexate +/- Ifosfamide." Dr. Paul Meyers, principal investigator, vice chairman, department of pediatrics at Memorial Sloan kettering Cancer Center Abstract #780 The 39th Congress of International Society of Pediatric Oncology (SIOP) -- Mumbai, India Poster presentation -- Friday,...

AngioGenex Files Patent on First Small Molecule Id-Inhibitors for the Treatment of Cancer

...d vessels into tumors (angiogenesis). The Company's technology is based on the research of Dr. Robert Benezra and his colleagues at the Memorial Sloan kettering Cancer Center (MSKCC) in New York City who established that activation of the Id genes is required for the formation of new blood vessels into tumors,...

Kosan's Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial

...hemotherapy. Data from the ongoing trial in patients with solid tumors were presented on Friday, September 7, 2007 by Shanu Modi, M.D., Memorial Sloan kettering Cancer Center, in a poster, titled, "Alvespimycin (KOS-1022) and Trastuzumab (T): Activity in HER2+ Metastatic Breast Cancer (MBC)" at the 2007 Breast...
Kettering in Biological News

Ohio Law Enforcement Agency Deploys BIO-key(R) Mobile Reporting Software

... MobileOffice(TM) Award from kettering Police Department Streamlines Incident and Crash Reporting WALL, N.J., July 1 /PRNewswire-FirstCall/ -- BIO-key International, ...

NYU and MSKCC research provides model for understanding chemically induced cancer initiation

... A team from the chemistry and biology departments of New York University, in collaboration with Memorial Sloan kettering Cancer Center (MSKCC), has uncovered a conformational switch--a change in shape in a carcinogen-damaged DNA site--in tumor suppressor genes altered by...

DuPont's first biologically derived polymer receives global recognition

...PE has membership of more than 20,000 plastics professionals in the United States and more than 70 countries around the world. Conference Chairman Tim kettering said, "The story of Sorona® is unique because it demonstrates that the use of renewable materials and processes can create new performance technologie...
Kettering in Biological Technology

Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors

...maintained an active faculty appointment, initially at Indiana University School of Medicine from 1997 to 1999 and, more recently, at Memorial Sloan kettering Cancer Center in New York from 2000 to 2008. Dr. Dhingra is currently heading KAPital Consulting LLC, a company dedicated to helping biotechnology, p...

AngioGenex Presents Data on its Id Targeted Anti-Angiogenesis Inhibitors at Two Scientific Conferences

... vessels into tumors (angiogenesis). The Company's technology is based on the research of Dr. Robert Benezra and his colleagues at the Memorial Sloan kettering Cancer Center (MSKCC) in New York City who established that activation of the Id genes is required for the formation of new blood vessels into tumors,...

AngioGenex Reviews 2008 Achievements and Sets Goals for 2009

... vessels into tumors (angiogenesis). The Company's technology is based on the research of Dr. Robert Benezra and his colleagues at the Memorial Sloan kettering Cancer Center (MSKCC) in New York City who established that activation of the Id genes is required for the formation of new blood vessels into tumors,...

AngioGenex Appoints New CEO to Direct Development of Anti-Cancer Drugs

...d vessels into tumors (angiogenesis). The Company's technology is based on the research of Dr. Robert Benezra and his colleagues at the Memorial Sloan kettering Cancer Center (MSKCC) in New York City who established that activation of the Id genes is required for the formation of new blood vessels into tumors,...

Bayer and Onyx Announce Nexavar Data Presentations at 44th American Society of Clinical Oncology Annual Meeting

...e in patients with hepatocellular carcinoma (HCC) in Child-Pugh B (CPB) Cirrhosis? -- Ghassan Abou-Alfa, MD, internal medicine, Memorial Sloan kettering Cancer Center, New York, NY -- Poster 6, abstract #4518, poster discussion, Tuesday, June 3, 2008, 11 - 11:15 a.m., S406 -- Effica...

International Confocal Microscopy Working Group Established to Advance Practice of Reflective Confocal Microscopy

...e broad acceptance of RCM for the diagnosis of skin cancers and conditions. The Working Group founders include Dr. Salvador Gonzalez of Memorial Sloan kettering Cancer Center (New York) and Ramon y Cajal Hospital (Madrid); Dr. Giovanni Pellacani of University of Modena and Reggio Emilia; Dr. Josep Malvehy of H...

BiPar Names Hoyoung Huh, M.D., Ph.D. President and Chief Executive Officer

... leveraging its exciting product platform in DNA repair." Dr. Huh received his M.D. and Ph.D. from Cornell University Medical College/Memorial Sloan kettering Cancer Center and his A.B. from Dartmouth College. About BiPar Sciences BiPar Sciences, Inc. ( http://www.biparsciences.com ) is a clinical-stage ...

Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer

... Hill Hospital, his residency in internal medicine at the Mayo Clinic and a fellowship in medical oncology and clinical pharmacology at Memorial Sloan kettering Cancer Center. About Poniard Pharmaceuticals Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercia...

William Garland Joins AngioGenex's New Board of Directors

...es or proteins. The company's proprietary technology is based primarily on the research of Dr. Robert Benezra and his colleagues at the Memorial Sloan kettering Cancer Center (MSKCC) in New York City. His research established that the Id genes and proteins are required for the formation of the new blood vessel...

Abiant, Inc. Announces Close on Investment Round

...er, owner of the Maier Consulting Group and a former Senior Partner with Arthur Andersen, and Rick Mace, Vice President, Clinical Services Division of kettering Medical Center, have joined Abiant's Board of Directors as part of this Offering. We are excited about supporting a technology that will change the wa...
Kettering in Biological Dictionary

Computational biology

.... Department of Computational Biology ... for Computational Biology and Bioinfromatics ... Computational Biology Center. Memorial Sloan kettering Cancer Center ... The aim of computation biology is to build computer models that simulate ... Computational biology can help interpret detai...
Other Tags
(Date:4/24/2014)... terminology, and the relevance of palliation in advanced ... randomized controlled trials (RCTs). This is the result ... Quality and Efficiency in Health Care (IQWiG), which ... Together with external experts, IQWiG analysed studies on ... malignant melanoma, and pancreatic cancer. For this purpose, ...
(Date:4/24/2014)... awarded one of 30 grants from the National Cancer ... Site in its new National Clinical Trials Network ... of investigators charged with distributing resources in a more ... system reflects recommendations from a 2010 Institute of ... goals:, Faster design, launch, and completion of ...
(Date:4/23/2014)... by Massachusetts General Hospital (MGH) investigators may lead to ... a serious medical problem use of fecal material ... the Clostridium difficile ( C. difficile ) ... the journal Clinical Infectious Diseases , the researchers ... donors unrelated to patients was as successful in curing ...
(Date:4/23/2014)... J. O,Shea, M.D., scientific director at the National Institute ... been named the 2014 recipient of the Ross Prize ... open-access journal Molecular Medicine . The award will ... Academy of Sciences in Manhattan, followed by scientific presentations ... part of the National Institutes of Health. , The ...
(Date:4/23/2014)... researchers have identified an important enzyme pathway that helps ... few chromosomes, a condition that has been directly linked ... professor of biochemistry, found that near the end of ... that ensures any breaks in DNA are fully repaired ... to daughter cells. This process helps safeguard against some ...
Breaking Medicine News(10 mins):Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3Health News:Dartmouth awarded lead role in NCI clinical trials network 2Health News:Dartmouth awarded lead role in NCI clinical trials network 3Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 2Health News:Use of frozen material for fecal transplant successfully treats C. difficile infection 3Health News:NIH scientist to receive Ross Prize in Molecular Medicine 2Health News:Study identifies enzymes that help fix cancer-causing DNA defects 2
(Date:4/23/2014)... contribute to early fetal death according to a new ... Children,s Hospital Los Angeles and Ulaanbaatar, Mongolia the ... paper published today in the journal BMC Pregnancy ... between seasonal ambient air pollutants and pregnancy loss in ... the highest levels of air pollution of all world ...
(Date:4/23/2014)... Like a hungry diner ripping open a dinner roll, ... must tear open a hydrogen molecule. Now researchers have ... the two halves of its hydrogen feast. The view ... make the catalyst work better for alternative energy uses. ... shown precisely where the hydrogen halves end up in ...
(Date:4/23/2014)... research shows that male black widow spiders prefer their ... example of mate preference by male spiders. ... and Maydianne Andrade, a professor in UTSC,s Department of ... the wild that males overwhelmingly chose to mate with ... can tell whether a potential mate is well-fed and ...
Breaking Biology News(10 mins):Pollutants from coal-burning stoves strongly associated with miscarriages in Mongolia 2Halving hydrogen 2Halving hydrogen 3Halving hydrogen 4Picky male black widow spiders prefer well-fed virgins 2
Other Contents